SCHEMBL31198766

SCHEMBL31198766

O=C(OCc1ccccc1)N1CCC(c2ccc(N3CCC(CCC4OCCO4)CC3)cc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 3/20 0.53
▸ MEN1 O00255 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ MAPT P10636 1/20 0.49
▸ CYP2C19 P33261 1/20 0.48
▸ FAAH O00519 2/20 0.48
▸ GRIN2B Q13224 8/20 0.47
▸ CYP2D6 P10635 4/20 0.46
▸ CYP2C9 P11712 4/20 0.46
▸ PDE4B Q07343 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ CYP3A4 P08684 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31198878 0.91 MEN1 (0.52) CHRM4MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL31198992 0.89 SMN1; SMN2 (0.62) CHRM4MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL25431193 0.86 MEN1 (0.53) CHRM4MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL31198723 0.81 MEN1 (0.52) CHRM4MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL31199071 0.81 MEN1 (0.47) CHRM4MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL31198857 0.80 GPR119 (0.57) SMN1; SMN2NPC1RAB9AMAPTCYP2C19
SCHEMBL31198952 0.80 SMN1; SMN2 (0.52) CHRM4MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL15140566 0.79 SMN1; SMN2 (0.72) CHRM4MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL4035554 0.79 SMN1; SMN2 (0.72) CHRM4MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL6749001 0.78 SMN1; SMN2 (0.67) CHRM4MEN1KMT2ANPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676922-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF DEGRADING ANDROGEN RECEPTORS Astrazeneca AB (SE) 2026-01-14 — — EP disclosed
WO-2024189488-A1 BIFUNCTIONAL COMPOUNDS CAPABLE OF DEGRADING ANDROGEN RECEPTORS ASTRAZENECA AB (SE) 2024-09-19 — — WO disclosed
Send feedback